You are here

Article Text

Article menu
Download PDFPDF
Electronic pages
Correspondence response
Step-up therapy remains an appropriate option
  1. Duncan R Porter
  1. Correspondence to Dr Duncan R Porter, Institute of Infection, Immunity and Inflammation, University of Glasgow, Gartnavel General Hospital, 1053 Great Western Road, Glasgow G12 0YN, UK; duncan.porter{at}glasgow.ac.uk

http://dx.doi.org/10.1136/annrheumdis-2013-203242

Statistics from Altmetric.com

    I congratulate the research team from Rotterdam for the high-quality study design of the treatment in the Rotterdam Early Arthritis Cohort (tREACH) study, but their conclusions are overstated.1 Their quotation of the literature is incomplete, referring to some studies of initial combination disease-modifying antirheumatic drugs (DMARDs) plus corticosteroid (BeSt, FinRACo, COBRA trial) but excluding some other studies that do not support their conclusions. There have been two previously published randomised controlled trials comparing the step-up and initial combination triple DMARD therapy, which show no sustained benefit of the initial …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions